[Springer] Assessing patient risk, benefit, and outcomes in drug development: a decade of sorafenib clinical trials |
|
This post will be closed automatically in 2026-10-31 17:24
Best Answer
5 day(s) ago
|
| |
20
[Single chapter]Nanopigments in Textiles
10
Reactive oxygen species in hypertension
15
Income Shocks, Financial Hardship, and Changes in Depression Symptomatology Among Older Americans During the First Year of the COVID-19 Pandemic
10
The Definition and Prevalence of Obesity and Metabolic Syndrome: Correlative Clinical Evaluation Based on Phenotypes
50
[Full book]Proceedings of the Joint International Conference: 5th Conference on Engineering and Entrepreneurship and 11th Textile Conference
